Received:14 November 2019,
Published:30 April 2020
移动端阅览
Bingyu LI, Weiyuan LIU, Xin LIN, et al. Effect of metformin on autophagy in human umbilical vein endothelial cells[J]. Journal of Third Military Medical University, 2020, 42(8): 783-789.
Bingyu LI, Weiyuan LIU, Xin LIN, et al. Effect of metformin on autophagy in human umbilical vein endothelial cells[J]. Journal of Third Military Medical University, 2020, 42(8): 783-789. DOI: 10.16016/j.1000-5404.201911118.
Objective
2
To observe the effects of metformin on the autophagy of endothelial cells and explore the underlying mechanism.
Methods
2
Human umbilical vein endothelial cells (HUVECs) were treated with 0
2.5
5
10
20 and 40 mmol/L metformin for 24 h or with 5 mmol/L metformin for 24
48 and 72 h
and cell survival after the treatment was assessed using CCK-8 assay. The formation of autophagosomes in HUVECs treated with metformin and transforming growth factor-β1 (TGF-β1)
alone or in combination
was observed with transmission electron microscopy
and the expression levels of autophagy-related molecules LC3II and Beclin-1 were detected using immunofluorescence assay and Western blotting. The effects of XMU-MP-1 (an inhibitor of Hippo signaling pathway) and verteporfin (a blocker of Hippo signal transcription factor YAP) in the absence or presence of metformin or TGF-β1 on the expression levels of LC3II
YAP
pYAP and CTGF (the target protein of pYAP) were detected using Western blotting.
Results
2
CCK-8 assay showed that compared with the control cells
HUVECs treated with 10
20 and 40 mmol/L metformin for 24 h exhibited significantly reduced cell survival rates (all
P
<
0.01)
and we therefore used 5 mmol/L metformin for 24 h in the subsequent experiments. The results of electron microscopy
immunofluorescence assay and Western blotting showed that treatment with TGF-β1 significantly increased the number of autophagosomes
enhanced the
expression of LC3II and Beclin-1 (
P
<
0.05)
lowered the expression of pYAP (
P
<
0.01)
and up-regulated CTGF expression in HUVECs (
P
<
0.01). These changes were significantly blocked by metformin. The expression of levels LC3II and CTGF were also inhibited in the cells by treatment with verteporfin and TGF-β1 (
P
<
0.01). XMU-MP-1 showed similar effects to TGF-β1 and significantly up-regulated the expression of LC3II (
P
<
0.01)
decreased the expression of pYAP (
P
<
0.01)
and enhanced the expression of CTGF (
P
<
0.01); such effects of XMU-MP-1 were also significantly blocked by metformin (all
P
<
0.05). The expression levels of CTGF and LC3II were obviously down-regulated in the cells treated with both verteporfin and XMU-MP-1 (
P
<
0.01).
Conclusion
2
Metformin may protect the veins by inhibiting TGF-β1-induced autophagy and blocking the activation of YAP signaling in the endothelial cells.
BRAHMBHATT A REMUZZI A FRANZONI M The molecular mechanisms of hemodialysis vascular access failure Kidney Int 2016 89 2 303 316 10.1016/j.kint.2015.12.019 https://www.ncbi.nlm.nih.gov/pubmed/26806833/ BRAHMBHATT A, REMUZZI A, FRANZONI M, et al . The molecular mechanisms of hemodialysis vascular access failure[J ] . Kidney Int, 2016, 89(2):303-316. DOI:10.1016/j.kint.2015.12.019.
TIAN D Y JIN X R ZENG X Notch signaling in endothelial cells:is it the therapeutic target for vascular neointimal hyperplasia? Int J Mol Sci 2017 18 8 1615 10.3390/ijms18081615 http://cn.bing.com/academic/profile?id=a718b5937d56e810d6178b2cbfddf4fe&encoded=0&v=paper_preview&mkt=zh-cn TIAN D Y, JIN X R, ZENG X, et al . Notch signaling in endothelial cells:is it the therapeutic target for vascular neointimal hyperplasia?[J ] . Int J Mol Sci, 2017, 18(8):1615. DOI:10.3390/ijms18081615.
WANG J FENG Y WANG Y Autophagy regulates Endothelial-Mesenchymal transition by decreasing the phosphorylation level of Smad3 Biochem Biophys Res Commun 2017 487 3 740 747 10.1016/j.bbrc.2017.04.130 WANG J, FENG Y, WANG Y, et al . Autophagy regulates Endothelial-Mesenchymal transition by decreasing the phosphorylation level of Smad3[J ] . Biochem Biophys Res Commun, 2017, 487(3):740-747. DOI:10.1016/j.bbrc.2017.04.130.
LUO X YANG D WU W Critical role of histone demethylase Jumonji domain-containing protein 3 in the regulation of neointima formation following vascular injury Cardiovasc Res 2018 114 14 1894 1906 10.1093/cvr/cvy176 http://cn.bing.com/academic/profile?id=bd55f88b95e58c6381705fe63e1d48d2&encoded=0&v=paper_preview&mkt=zh-cn LUO X, YANG D, WU W, et al . Critical role of histone demethylase Jumonji domain-containing protein 3 in the regulation of neointima formation following vascular injury[J ] . Cardiovasc Res, 2018, 114(14):1894-1906. DOI:10.1093/cvr/cvy176.
CHANG Y J HUANG H C HSUEH Y Y Role of excessive autophagy induced by mechanical overload in vein graft neointima formation:prediction and prevention Sci Rep 2016 6 22147 10.1038/srep22147 https://www.ncbi.nlm.nih.gov/pubmed/26915560 CHANG Y J, HUANG H C, HSUEH Y Y, et al . Role of excessive autophagy induced by mechanical overload in vein graft neointima formation:prediction and prevention[J ] . Sci Rep, 2016, 6:22147. DOI:10.1038/srep22147.
LU J JI J MENG H The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats Cardiovasc Diabetol 2013 12 58 10.1186/1475-2840-12-58 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642024/ LU J, JI J, MENG H, et al . The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats[J ] . Cardiovasc Diabetol, 2013, 12:58. DOI:10.1186/1475-2840-12-58.
ALLOUCH S MUNUSAMY S Metformin attenuates albumin-induced alterations in renal tubular cells in vitro J Cell Physiol 2017 232 12 3652 3663 10.1002/jcp.25838 https://onlinelibrary.wiley.com/doi/full/10.1002/jcp.25838 ALLOUCH S, MUNUSAMY S. Metformin attenuates albumin-induced alterations in renal tubular cells in vitro[J]. J Cell Physiol, 2017, 232(12):3652-3663. DOI:10.1002/jcp.25838.
MENG Z MOROISHI T GUAN K L Mechanisms of Hippo pathway regulation Genes Develop 2016 30 1 1 17 10.1101/gad.274027.115 MENG Z, MOROISHI T, GUAN K L. Mechanisms of Hippo pathway regulation[J]. Genes Develop, 2016, 30(1):1-17. DOI:10.1101/gad.274027.115.
YU Q LI W JIN R PI3Kγ (phosphoinositide 3-kinase γ) regulates vascular smooth muscle cell phenotypic modulation and neointimal formation through CREB (cyclic AMP-response element binding protein)/YAP (yes-associated protein) signaling Arterioscl, Throm Vasc Biol 2019 39 3 e91 e105 10.1161/ATVBAHA.118.312212 YU Q, LI W, JIN R, et al . PI3Kγ (phosphoinositide 3-kinase γ) regulates vascular smooth muscle cell phenotypic modulation and neointimal formation through CREB (cyclic AMP-response element binding protein)/YAP (yes-associated protein) signaling[J ] . Arterioscl, Throm Vasc Biol, 2019, 39(3):e91-e105. DOI:10.1161/ATVBAHA.118.312212.
MORISHITA T HAYAKAWA F SUGIMOTO K The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib Oncotarget 2016 7 35 56241 56252 10.18632/oncotarget.11025 MORISHITA T, HAYAKAWA F, SUGIMOTO K, et al . The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib[J ] . Oncotarget, 2016, 7(35):56241-56252. DOI:10.18632/oncotarget.11025.
WANG Y LIANG A LUO J Blocking Notch in endothelial cells prevents arteriovenous fistula failure despite CKD J Am Soc Nephrol 2014 25 4 773 783 10.1681/ASN.2013050490 WANG Y, LIANG A, LUO J, et al . Blocking Notch in endothelial cells prevents arteriovenous fistula failure despite CKD[J ] . J Am Soc Nephrol, 2014, 25(4):773-783. DOI:10.1681/ASN.2013050490.
PODHORECKA M IBANEZ B DMOSZYN'SKA A Metformin—its potential anti-cancer and anti-aging effects Postepy Hig Med Dosw 2017 71 170 175 10.5604/01.3001.0010.3801 PODHORECKA M, IBANEZ B, DMOSZYN'SKA A. Metformin—its potential anti-cancer and anti-aging effects[J]. Postepy Hig Med Dosw, 2017, 71:170-175. DOI:10.5604/01.3001.0010.3801.
YAO L HE J LI B Regulation of YAP by mammalian target of rapamycin complex 1 in endothelial cells controls blood pressure through COX-2/mPGES-1/PGE cascade Hypertension 2019 74 4 936 946 10.1161/hypertensionaha.119.12834 YAO L, HE J, LI B, et al . Regulation of YAP by mammalian target of rapamycin complex 1 in endothelial cells controls blood pressure through COX-2/mPGES-1/PGE cascade[J ] . Hypertension, 2019, 74(4):936-946. DOI:10.1161/hypertensionaha.119.12834.
ZHOU W ZHAO M How Hippo signaling pathway modulates cardiovascular development and diseases J Immunol Res 2018 2018 3696914 3696914 10.1155/2018/3696914 ZHOU W, ZHAO M. How Hippo signaling pathway modulates cardiovascular development and diseases[J]. J Immunol Res, 2018, 2018:3696914-3696914. DOI:10.1155/2018/3696914.
BASU-ROY U BAYIN N S RATTANAKORN K Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells Nat Commun 2015 6 6411 10.1038/ncomms7411 BASU-ROY U, BAYIN N S, RATTANAKORN K, et al . Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells[J ] . Nat Commun, 2015, 6:6411. DOI:10.1038/ncomms7411.
MA R REN J M LI P Activated YAP causes renal damage of type 2 diabetic nephropathy Eur Rev Med Pharmacol Sci 2019 23 2 755 763 10.26355/eurrev_201901_16890 MA R, REN J M, LI P, et al . Activated YAP causes renal damage of type 2 diabetic nephropathy[J ] . Eur Rev Med Pharmacol Sci, 2019, 23(2):755-763. DOI:10.26355/eurrev_201901_16890.
FAN F HE Z KONG LL Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration Sci Transl Med 2016 8 352 352ra108 10.1126/scitranslmed.aaf2304 FAN F, HE Z, KONG LL, et al . Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration[J ] . Sci Transl Med, 2016, 8(352):352ra108. DOI:10.1126/scitranslmed.aaf2304.
ZHANG L HE X LIU X Single-cell transcriptomics in medulloblastoma reveals tumor-initiating progenitors and oncogenic cascades during tumorigenesis and relapse Cancer Cell 2019 36 3 302 318 10.1016/j.ccell.2019.07.009 ZHANG L, HE X, LIU X, et al . Single-cell transcriptomics in medulloblastoma reveals tumor-initiating progenitors and oncogenic cascades during tumorigenesis and relapse[J ] . Cancer Cell, 2019, 36(3):302-318 e307. DOI:10.1016/j.ccell.2019.07.009.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
